Skip to main content

Table 2 Quality of Life Enjoyment and Satisfaction Questionnaire–Short Form Scoresa Over Time, Aripiprazole Lauroxil Group

From: Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study

  Week 5 Week 13 Week 25
All patients (observed cases)
 Total score, n 73 65 57
  Mean (SD) 48.7 (11.2) 48.7 (10.1) 49.0 (11.5)
 Satisfaction with Medication, n 67 63 52
  Mean (SD) 3.9 (1.0) 3.8 (1.0) 3.8 (0.9)
 Overall Life Satisfaction, n 73 65 57
  Mean (SD) 3.9 (1.0) 3.7 (0.9) 3.8 (1.0)
Patients who completed 25 weeks of treatmentb
 Total score, n 57 57 57
  Mean (SD) 49.2 (10.3) 49.1 (9.3) 49.0 (11.5)
 Satisfaction with Medication, n 52 55 52
  Mean (SD) 4.0 (0.8) 3.9 (0.9) 3.8 (0.9)
 Overall Life Satisfaction, n 57 57 57
  Mean (SD) 3.8 (0.9) 3.7 (0.9) 3.8 (1.0)
  1. aMaximum total score: 70
  2. bAll patients who had Quality of Life Enjoyment and Satisfaction Questionnaire–Short Form data at weeks 5 and 25